National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Treatment Choices for Men With Early-Stage Prostate Cancer
    Posted: 02/14/2006



Introduction






Facts about Prostate Cancer






Thinking About Treatment Choices






Comparing Your Treatment Options






Making a Choice About Treatment






Resources



Page Options
Print This Page
Print This Document
View Entire Document
E-Mail This Document
View/Print PDF
Order Free Copy
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
The Nation's Investment in Cancer Research FY 2010

Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
11. How long can I expect to live after I have this treatment?

Watchful Waiting, Surgery, and Radiation Therapy

Depending on age and the nature of the disease, a man with cancer confined to the prostate can lead a long and healthy life.

The 5-year survival rate for men with early-stage prostate cancer is nearly 100 percent. The 10-year survival rate is 86 percent and the 15-year survival rate is 56 percent. The average age of men at diagnosis is 65 years old.

And even if the cancer comes back, there are many treatment options that are known to be effective.

< Previous Question  |  Back to Questions List  





< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov